AI MARKET SCANNING

$RARE

Ultragenyx Pharmaceutical Inc.

United StatesUNITED STATES
FREE PREVIEW
AVG HISTORICAL GAP0.92%
MAX GAP RECORD-10.97%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

QUANTITATIVE LIVE RADAR BLOTTER

Institutional execution stream for $RARE

EXECUTIONS0
WIN RATE••.•%
NET ROI+•••.••%
Execution DateStrategy & SetupDirectionExecution RangeHold TimeExit TriggerNet PnL
RADAR SCANNING: WAITING FOR NEXT CATALYST
🔒 Institutional Data Protected

Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.

UNLOCK FULL BLOTTER

VOLATILITY & BIAS PROFILE

AVG VOLATILITY4.3%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL

AI INSIGHTS & REPORTS FOR $RARE

AI REPORT
Sep 07

Optimizing Your Portfolio Strategy: Navigating Market Volatility with Precision

AnalysisMarkets are navigating a treacherous path, with volatility spiking as global macroeconomic factors collide. The recent sell-off, fueled…
AI REPORT
Jul 10

Daily Champion Stocks: Top 3 Opportunities You Can’t Afford to Miss

Analysis Discover how Daily Champions are driving the market with these top-performing stocks. Whether you’re a seasoned investor…